Derivation and validation of a predictive model for advanced colorectal neoplasia in asymptomatic adults

dc.contributor.authorImperiale, Thomas F.
dc.contributor.authorMonahan, Patrick O.
dc.contributor.authorStump, Timothy E.
dc.contributor.authorRansohoff, David F.
dc.contributor.departmentMedicine, School of Medicineen_US
dc.date.accessioned2022-03-21T16:04:24Z
dc.date.available2022-03-21T16:04:24Z
dc.date.issued2021
dc.description.abstractObjective Knowing risk for advanced colorectal neoplasia (AN) could help patients and providers choose among screening tests, improving screening efficiency and uptake. We created a risk prediction model for AN to help decide which test might be preferred, a use not considered for existing models. Design Average-risk 50-to-80-year olds undergoing first-time screening colonoscopy were recruited from endoscopy units in Indiana. We measured sociodemographic and physical features, medical and family history and lifestyle factors and linked these to the most advanced finding. We derived a risk equation on two-thirds of the sample and assigned points to each variable to create a risk score. Scores with comparable risks were collapsed into risk categories. The model and score were tested on the remaining sample. Results Among 3025 subjects in the derivation set (mean age 57.3 (6.5) years; 52% women), AN prevalence was 9.4%. The 13-variable model (c-statistic=0.77) produced three risk groups with AN risks of 1.5% (95% CI 0.72% to 2.74%), 7.06% (CI 5.89% to 8.38%) and 27.26% (CI 23.47% to 31.30%) in low-risk, intermediate-risk and high-risk groups (p value <0.001), containing 23%, 59% and 18% of subjects, respectively. In the validation set of 1475 subjects (AN prevalence of 8.4%), model performance was comparable (c-statistic=0.78), with AN risks of 2.73% (CI 1.25% to 5.11%), 5.57% (CI 4.12% to 7.34%) and 25.79% (CI 20.51% to 31.66%) in low-risk, intermediate-risk and high-risk subgroups, respectively (p<0.001), containing proportions of 23%, 59% and 18%. Conclusion Among average-risk persons, this model estimates AN risk with high discrimination, identifying a lower risk subgroup that may be screened non-invasively and a higher risk subgroup for which colonoscopy may be preferred. The model could help guide patient–provider discussions of screening options, may increase screening adherence and conserve colonoscopy resources.en_US
dc.eprint.versionAuthor's manuscripten_US
dc.identifier.citationImperiale, T. F., Monahan, P. O., Stump, T. E., & Ransohoff, D. F. (2021). Derivation and validation of a predictive model for advanced colorectal neoplasia in asymptomatic adults. Gut, 70(6), 1155–1161. https://doi.org/10.1136/gutjnl-2020-321698en_US
dc.identifier.urihttps://hdl.handle.net/1805/28210
dc.language.isoenen_US
dc.publisherBMJen_US
dc.relation.isversionof10.1136/gutjnl-2020-321698en_US
dc.relation.journalGuten_US
dc.rightsPublisher Policyen_US
dc.sourceAuthoren_US
dc.subjectcolorectal cancer screeningen_US
dc.subjectcancer preventionen_US
dc.subjectcolonoscopyen_US
dc.titleDerivation and validation of a predictive model for advanced colorectal neoplasia in asymptomatic adultsen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Imperiale2021Derivation-AAM.pdf
Size:
636.82 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: